简体中文

Newsroom

News January 25, 2021

QuaCell Biotechnology's Notice on Strengthening the Disinfection of Product Packaging before Shipment

QuaCell Biotechnology implements temporary outer packaging disinfection measures to deliver the full line of cell culture media, culture supplement products, and technical service deliveries.
Learn More
News January 6, 2021

The Zhongshan CPPCC Proposal Research Group Visited Quacell Biotechnology

On the morning of August 29th, the Chinese People's Political Consultative Conference (CPPCC) Proposal Research Group composed of Zhongshan Municipal Science and Technology Bureau, Zhongshan Municipal Industry and Information Technology Bureau, Administration of Education and Sport of Zhongshan Municipality, Zhongshan Municipal Human Resources and Social Security Bureau visited Quacell Biotechnology for investigation.
Learn More
News December 19, 2020

Dr. H.Fai Poon participated in the Guangzhou Biomedical Innovation R&D Forum

On December 19, 2020, Dr. H.Fai Poon, CEO of QuaCell Biotechnology, Co., Ltd. (hereinafter referred to as "QuaCell"), was invited to participate in Guangzhou Biomedical Innovation and R&D Forum of the 2020 International Trade Fair.
Learn More
News December 15, 2020

Dr H.Fai Poon was invited to participate in the 2020 Hong Kong Entrepreneur Youth Mainland Trip

Dr H.Fai Poon, CEO of QuaCell Biotechnology, was invited to participate in the 2020 Hong Kong Entrepreneur Youth Mainland Tour and Greater Bay Area Entrepreneur Youth Online Exchange to share his entrepreneurial journey.
Learn More
News December 9, 2020

The Mayor of Zhongshan Wei Hanwei visited QuaCell Biotechnology

On December 9, 2020, the mayor of Zhongshan Weiweihan and his entourage visited QuaCell Biotechnology, Co., Ltd. (hereinafter referred to as "QuaCell") for investigation and tour guidance.
Learn More
News November 17, 2020

QuaCell® Serum-Free Cell Cryopreservation Solution Obtained the First Class Medical Device Recording Certificate

On October 28, 2020, Zhongshan City Market Supervision and Administration Bureau issued the first-class medical device registration certificate to our company for QuaCell® Serum-free Cell Cryopreservation Solution (Cat. No.: B31001).
Learn More
News September 21, 2020

BioInno and QuaCell Biotechnology reached a strategic cooperation on the CHO-K1Q Host Cell Platform

Suzhou BioInno Bioscience Co., Ltd. (hereinafter referred to as "BioInno Bioscience") and Zhongshan QuaCell Biotechnology Co., Ltd. (hereinafter referred to as "QuaCell Biotechnology") jointly announced that the two parties will reach a strategic cooperation intention on the introduction of the CHO-K1Q host cell platform and the cooperation of CDMO service projects.
Learn More
News September 9, 2020

Greater Bay Area Planning | Dr. H. Fai Poon, CEO of QuaCell Biotechnology, was invited to share the cooperation policy recommendations of the Association for Science and Technology

In August 2020, the Hong Kong Association for Science and Technology, Director Xue and Deputy Director Zhong of the Hong Kong Innovation and Technology Bureau conducted a discussion on why Zhongshan was chosen as the pilot for the start-up park. Dr.H. Fai Poon, CEO of QuaCell Biotechnology, was invited to participate in the sharing.
Learn More
News September 3, 2020

Bioworkshops and QuaCell Biotechnology reach strategic cooperation on the CHO-K1Q host cell platform

On September 3rd, Bioworkshops and QuaCell Biotechnology reached strategic cooperation intention of introducing the CHO-K1Q host cell platform and cooperating in CDMO service projects.
Learn More
News April 16, 2020

Accelerate the R&D of COVID-19 Vaccine | QuaCell and SYSVAX reached a Strategic Cooperation

On April 16, 2020, QuaCell Biotechnology, Co., Ltd. (QuaCell) signed a framework agreement for strategic cooperation with SYSVAX INC. in Zhongshan, Guangdong.
Learn More